March 02, 2023 — 09:56 pm EST

      Written by
                        RTTNews.com for                             
        




RTTNews ->


(RTTNews) - Revolution Medicines Inc. (RVMD) said that it priced its underwritten public offering of 13.64 million shares of common stock at a public offering price of $22.00 per share, before underwriting discounts and commissions.
In addition, Revolution Medicines has granted the underwriters a 30-day option to purchase up to an additional 2.05 million shares of common stock at the public offering price, less underwriting discounts and commissions.
The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Revolution Medicines, are expected to be $300.0 million, excluding any exercise of the underwriters' option to purchase additional shares.
The offering is expected to close on March 7, 2023. 
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

© 2023, Nasdaq, Inc. All Rights Reserved.










To add symbols:


These symbols will be available throughout the site during your session.
To add symbols:


These symbols will be available throughout the site during your session.